Related Experiment Video
Updated: Apr 30, 2026

Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
Pharmacokinetics and pharmacodynamics of two vitamin K1 formulations in rats
1Center of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing, China.
Purpose:
Severe allergic reactions associated with the commercially available formulation of vitamin K1 injection (VKI) could be a result of polysorbate that was added to solubilize vitamin K1 (VK1). Hence, we sought to develop vitamin K1 lipid emulsion (VKLE) devoid of polysorbate, in order to reduce the clinical risk of severe allergic reactions. This study aims to evaluate the pharmacokinetics and pharmacodynamics of VKLE in comparison to VKI in rats.
Methods:
Plasma concentration-time profiles of VK1 were investigated in rats after dosing VKLE or VKI at the range of 1-4 mg/kg. Tissue distribution of VKLE and VKI were investigated in rats at the dose of 2 mg/kg. The pharmacodynamics of VKLE and VKI were also studied by comparing their effects on coagulation factors (II/VII/IX/X) and prothrombin time in hypoprothrombinemic rats.
Results:
VKI demonstrated over-proportional increase in AUC at the dosage range of 1.0-4.0 mg/kg, whereas VKLE demonstrated a linear kinetics trend in general. Compared to VKI, VKLE could selectively deliver VK1 to the liver, spleen and heart. VKLE and VKI produced comparable maximal responses, in terms of coagulation factors and prothrombin time.
Conclusions:
VKLE and VKI demonstrated different pharmacokinetics but comparable pharmacodynamics in rats.
Related Concept Videos
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Measurement of Bioavailability: Pharmacokinetic Methods
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Determination of Michaelis Constant and Maximum Elimination Rate
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
Two-Compartment Open Model: IV Bolus Administration
The disparity between drug input and the sum of drug transfer rates between...

